论著
ENGLISH ABSTRACT
支气管扩张症患者咯血与疾病严重程度和急性加重的关系
关伟杰
袁婧婧
高永华
李惠敏
钟南山
陈荣昌
作者及单位信息
·
DOI: 10.3760/cma.j.issn.1001-0939.2017.01.005
Hemoptysis in adults with bronchiectasis: correlation with disease severity and exacerbation risk
Guan Weijie
Yuan Jingjing
Gao Yonghua
Li Huimin
Zhong Nanshan
Chen Rongchang
Authors Info & Affiliations
Guan Weijie
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510120, China
Yuan Jingjing
Gao Yonghua
Li Huimin
Zhong Nanshan
Chen Rongchang
·
DOI: 10.3760/cma.j.issn.1001-0939.2017.01.005
2414
188
1
1
10
1
PDF下载
APP内阅读
摘要

目的评估支气管扩张症(支扩症)患者咯血与疾病严重程度和急性加重的关系。

方法于2012年9月至2014年1月纳入148例稳定期支扩症患者,男56例,例女92例,平均年龄44.6岁。咯血组106例,男36例,女70例,平均年龄45.6岁;未咯血组42例,男20,女22例,平均年龄41.8岁。采集既往病史,评价胸部影像学、肺功能、辣椒素激发试验相关的咳嗽敏感性及气道炎症特征。对患者进行1年随访以判断咯血能否预测支扩症急性加重的风险。

结果咯血组24 h痰量中位数为20 ml,支扩症严重程度指数中位数为7.0,受累肺叶中位数为4.0个,胸部CT评分中位数为7.0分,胸部CT提示存在囊状支扩病变67例(63%),肺部空洞形成52例(49%),铜绿假单胞菌定植35例(33%),辣椒素激发试验测定的咳嗽敏感度(引起≥5次咳嗽的辣椒素浓度)的几何均数为77 μmol/L。未咯血组24 h痰量中位数为5.0 ml,支扩严重程度指数中位数为4.0,受累肺叶中位数为3.0个,胸部CT评分中位数为5.0分,囊状支扩15例(36%),肺部空洞形成10例(24%),铜绿假单胞菌定植4例(10%),辣椒素激发试验测定的咳嗽敏感度的几何均数为212 μmol/L。以上指标两组比较差异均有统计学意义(均 P<0.05)。咯血组在入组前2年内因治疗急性加重而静脉滴注抗生素者29例(27%),住院治疗44例(42%);未咯血组在入组前2年内因治疗急性加重而静脉滴注抗生素8例(19%),住院治疗8例(19%)。经性别、年龄、吸烟状况、支扩严重程度指数校正后,咯血组在1年随访期内急性加重的风险更高(咯血组62例、未咯血组18例出现过急性加重,χ 2=16.06, P=0.03)。胸部CT提示存在囊状支扩的患者其咯血风险更高,咯血组67例(63%),未咯血组15例(36%),比值比为2.84(95%可信区间为1.00~8.14, P=0.05)。

结论72%(106例)的支扩症患者出现过咯血,且咯血与疾病严重程度呈正相关;咯血患者较未咯血患者在随访期的急性加重风险更高。

支气管扩张症;咯血;疾病严重程度
ABSTRACT

ObjectiveTo investigate the association between hemoptysis and disease severity and risks of acute exacerbations in patients with bronchiectasis.

MethodsBetween September 2012 and January 2014, we recruited 148 patients (56 males, 92 females, mean age: 44.6 years) with clinically stable bronchiectasis, who were classified into hemoptysis group (36 males, 70 females, mean age: 45.6 years) and non-hemoptysis group (20 males, 22 females, mean age: 41.8 years). We inquired the past history, and evaluated chest imaging characteristics, lung function, cough sensitivity assessed using capsaicin cough challenge tests, and airway inflammation. We also performed a 1-year follow-up to evaluate whether patients with hemoptysis would have greater risk of having acute exacerbations.

ResultsIn the hemoptysis group, median 24-hour sputum volume was 20.0 ml, median Bronchiectasis Severity Index (BSI) was 7.0, median bronchiectatic lobes was 4.0, median chest CT score was 7.0, the geometric mean for eliciting 5 coughs following capsaicin cough sensitivity (C5) was 77 μmol/L, 67 cases (63%) had cystic bronchiectasis and 52 cases (49%) had pulmonary cavity shown on chest CT, and 35 cases (33%) had Pseudomonas aeruginosa colonization. In the non-hemoptysis group, median 24-hour sputum volume was 5.0 ml, median BSI was 4.0, median bronchiectatic lobes was 3.0, median chest CT score was 5.0, 15 cases (36%) had cystic bronchiectasis and 10 cases (24%) had pulmonary cavity, the geometric mean for C5 was 212 μmol/L, and 4 cases (10%) had Pseudomonas aeruginosa colonization. All the above parameters differed significantly between the hemoptysis and the non-hemoptysis group ( P<0.05). In the hemoptysis group, 29 patients with pulmonary cavity (27%) had reported the use of intravenous antibiotics, and 44 cases (42%) had at least one hospitalization within the previous 2 years. In the non-hemoptysis group, 8 cases (19.0%) had reported the use of intravenous antibiotics, and 8 cases (19.0%) reported hospitalization within 2 years. A prior history of hemoptysis was associated with a greater risk of experiencing bronchiectasis exacerbations during follow-up, after adjusting for age, sex, smoking status and BSI (62 cases in the hemoptysis group, 18 cases in the non-hemoptysis group, χ 2=16.06, P=0.03). In a multivariate model, cystic bronchiectasis was the sole risk factor for hemoptysis; 67 cases which accounted for 63% of patients in the hemoptysis group and 15 cases which accounted for 36% of patients in the non-hemoptysis group, odds ratio: 2.84, 95% confidence interval: 1.00-8.14, P=0.05 .

ConclusionsIn this study, 72% of bronchiectasis patients had experienced hemoptysis, which was associated with the severity of bronchiectasis. Patients with a prior history of hemoptysis had a greater risk of acute exacerbations during follow-up than those without.

Bronchiectasis;Hemoptysis;Disease severity
Chen Rongchang, Email: mocdef.3ab61.pivcrnehc
The National Key Technology R&D Program of the 12th National Five-year Development Plan (2012BAI05B01), National Key Scientific & Technology Support Program: Collaborative Innovation of Clinical Research for Chronic Obstructive Pulmonary Disease and Lung Cancer(2013BAI09B09); National Natural Science Foundation(81400010), Changjiang Scholars and Innovative Research Team in University (ITR0961), Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University(2014C21)
引用本文

关伟杰,袁婧婧,高永华,等. 支气管扩张症患者咯血与疾病严重程度和急性加重的关系[J]. 中华结核和呼吸杂志,2017,40(1):16-23.

DOI:10.3760/cma.j.issn.1001-0939.2017.01.005

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
支气管扩张症(支扩症)是慢性气道感染性疾病,其特征性症状包括慢性咳嗽、咳痰及咯血等 [ 1 ]。咯血并不少见且是患者求医甚至住院治疗的主要原因 [ 2 ]。造成支扩症咯血的原因尚未完全清楚,可能包括气道炎症所致的血管通透性增高、动静脉瘘、用力咳嗽所致支气管动脉压力瞬时增高及机械性牵张所致支气管动脉破裂。
咯血具有较大的异质性,部分患者主诉咯血丝痰、血痰,部分出现危及生命的大咯血 [ 3 , 4 ]。笔者发现,尽管其他症状不突出或疾病严重程度较低,但咯血对支扩症患者的生活质量影响较为显著,不少患者因频繁咯血而出现抑郁和焦虑 [ 5 , 6 ]。与其他慢性呼吸系统疾病(如支气管哮喘、慢阻肺)相比,支扩症的药物或物理治疗手段有限 [ 7 ],疗效不够明确,目前支扩症患者的咯血以对症处理为主。我国现仍缺乏对支扩症的研究,对该病的认识来源于经验总结或国外的诊疗规范,因此,总结我国支扩症患者的发病特征,探讨咯血对支扩症的临床影响有重要意义。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
成人支气管扩张症诊治专家共识编写组. 成人支气管扩张诊治专家共识[J]. 中华结核和呼吸杂志 201235(7):485-492. DOI: 10.3877/cma.j.issn.1674-6880.2012.07.003 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Lee BR , Yu JY , Ban HJ ,et al. Analysis of patients with hemoptysis in a tertiary referral hospital[J]. Tuberc Respir Dis (Seoul) 201273(2):107-114. DOI: 10.4046/trd.2012.73.2.107 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Abdulmalak C , Cottenet J , Beltramo G ,et al. Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database[J]. Eur Respir J 201546(2):503-511. DOI: 10.1183/09031936.00218214 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Earwood JS , Thompson TD . Hemoptysis: evaluation and management[J]. Am Fam Physician 201591(4):243-249.
返回引文位置Google Scholar
百度学术
万方数据
[5]
Gao Y , Guan W , Xu G ,et al. Sleep disturbances and health-related quality of life in adults with clinically stable bronchiectasis[J]. PLoS One 20149(7):e102970. DOI: 10.1371/journal.pone.0102970 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Girón Moreno RM , Fernandes Vasconcelos G , Cisneros C ,et al. Presence of anxiety and depression in patients with bronchiectasis unrelated to cystic fibrosis[J]. Arch Bronconeumol 201349(10):415-420. DOI: 10.1016/j.arbres.2013.01.012 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Chalmers JD , Aliberti S , Blasi F . Management of bronchiectasis in adults[J]. Eur Respir J 201545(5):1446-1462. DOI: 10.1183/09031936.00119114 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Guan WJ , Gao YH , Xu G ,et al. Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China[J]. Int J Tubercul Lung Dis 201519(5):610-619. DOI: 10.5588/ijtld.14.0613 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Guan WJ , Gao YH , Xu G ,et al. Characterization of lung function impairment in adults with bronchiectasis[J]. PLoS One 20149(11):e113373. DOI: 10.1371/journal.pone.0113373 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Guan WJ , Gao YH , Xu G ,et al. Impulse oscillometry in adults with bronchiectasis[J]. Ann Am Thorac Soc 201512(5):657-665. DOI: 10.1513/AnnalsATS.201406-280OC .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Guan WJ , Gao YH , Xu G ,et al. Aetiology of bronchiectasis in Guangzhou, southern China[J]. Respirology 201520(5):739-748. DOI: 10.1111/resp.12528 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Guan WJ , Gao YH , Xu G ,et al. Capsaicin cough sensitivity and the association with clinical parameters in bronchiectasis[J]. PLoS One 20149(11):e113057. DOI: 10.1371/journal.pone.0113057 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Chalmers JD , Goeminne P , Aliberti S ,et al. The bronchiectasis severity index: an international derivation and validation study[J]. Am J Respir Crit Care Med 2014189(5):576-585. DOI: 10.1164/rccm.201309-1575OC .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Jang EJ , Lee CH , Yoon HI ,et al. Association between inhaler use and risk of haemoptysis in patients with non-cystic fibrosis bronchiectasis[J]. Respirology 201520(8):1213-1221. DOI: 10.1111/resp.12618 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Lee JK , Lee J , Park SS ,et al. Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis[J]. Int J Tuberc Lung Dis 201418(3):363-370. DOI: 10.5588/ijtld.13.0255 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Gorur R , Turut H , Yiyit N ,et al. The influence of specific factors on postoperative morbidity in young adults with bronchiectasis[J]. Heart Lung Circ 201120(7):468-472. DOI: 10.1016/j.hlc.2011.03.011 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Ghanaati H , Shakouri Rad A , Firouznia K ,et al. Bronchial artery embolization in life-threatening massive hemoptysis[J]. Iran Red Crescent Med J 201315(12):e16618. DOI: 10.5812/ircmj.16618 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Wong C , Jayaram L , Karalus N ,et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial[J]. Lancet 2012380(9842):660-667. DOI: 10.1016/S0140-6736(12)60953-2 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Tsang KW , Ho PL , Lam WK ,et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis[J]. Am J Respir Crit Care Med 1998158(3):723-727. DOI: 10.1164/ajrccm.158.3.9710090 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Coutinho D , Fernandes P , Guerra M ,et al. Surgical treatment of bronchiectasis: a review of 20 years of experience[J]. Rev Port Pneumol (2006) 201622(2):82-85. DOI: 10.1016/j.rppnen.2015.09.007 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Al-Refaie RE , Amer S , El-Shabrawy M . Surgical treatment of bronchiectasis: a retrospective observational study of 138 patients[J]. J Thorac Dis 20135(3):228-233. DOI: 10.3978/j.issn.2072-1439.2013.04.11 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
陈荣昌,Email: mocdef.3ab61.pivcrnehc
B
国家重点技术研发基金"十二五"计划 (2012BAI05B01)
国家重点科技支撑计划:慢性阻塞性肺疾病与肺癌协同创新研究计划 (2013BAI09B09)
国家自然科学基金青年基金 (81400010)
长江学者及大学创新研究团队基金 (ITR0961)
广州医科大学医学博士与留学归国人员启动基金 (2014C21)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号